Document Type : Original Research


1 Dept. of Pathology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

2 Dept. of Gynecology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran


Background and Objectives: Infection with parvovirus may induce spontaneous abortion, non-immune hydrops fetalis, and intrauterine death in full term infants. The aim of this study was to determine the frequency of parvovirus B19 in paraffin-embedded formalin fixed placental tissues in lost fetuses by PCR method and comparison with its frequency in healthy full term neonates as controls.
Materials and Methods: In a case control study, thirty-one formalin fixed paraffin embedded placental tissue from autopsies related to fetal losses and also the same number of control cases were collected and The PCR for internal control and target sequence were performed.
 Results: Thirty-one subjects and 31 controls were enrolled and three out of 31 cases were positive for parvovirus (9.7%) using PCR. Hydropic changes were noted in two of   positive cases for parvovirus.
Conclusion: Parvovirus B19 infection during pregnancy may cause red precursor cells damage resulting in anemia and congestive heart failure. We suggest that studies with greater sample sizes are carried out to determine the frequency and management of parvovirus B19 infection because of timely diagnosis and transfusion of severe hydropic fetuses can reduce the risk of fetal death


  1. Rodis JF. Parvovirus infection. Clin Obstet Gynecol 1999;42(1):107-20.
  2. Bonvicini F, Manaresi E, Gallinella G, Gentilomi GA, Musiani M, Zerbini M. Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. BJOG 2009;116(6):813-7.
  3. Enders M, Klingel K, Weidner A, Baisch C, Kandolf R, Schalasta G, et al.. Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection. J Clin Virol 2010;49(3):163-8.
  4. Yaegashi N. Pathogenesis of nonimmune hydrops fetalis caused by intrauterine B19 infection. Tohoku J Exp Med 2000;190(2):65-82.
  5. Weigel-Kelley KA, Yoder MC, Chen L, Srivastava A. Role of integrin cross-regulation in parvovirus B19 targeting. Hum Gene Ther 2006;17(9):909-20.
  6. Wattre P, Dewilde A, Subtil D, Andreoletti L, Thirion V. A clinical and epidemiological study of human parvovirus B19 infection in fetal hydrops using PCR Southern blot hybridization and chemiluminescence detection. J Med Virol 1998;54(2):140-4.
  7. Fairley CK, Smoleniec JS, Caul OE, Miller E. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 1995 ;346(8986):1335-7.
  8. Cosmi E, Mari G, Delle CL, Detti L, Akiyama M, Murphy J, et al.. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol 2002;187(5):1290-3.
  9. Pryde PG, Nugent CE, Pridjian G, Barr M, Jr., Faix RG. Spontaneous resolution of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Obstet Gynecol 1992;79(5 ( Pt 2):859-61.
  10. Nyman M, Tolfvenstam T, Petersson K, Krassny C, Skjoldebrand-Sparre L, Broliden K. Detection of human parvovirus B19 infection in first-trimester fetal loss. Obstet Gynecol 2002;99(5 Pt 1):795-8.
  11. Skjoldebrand-Sparre L, Nyman M, Broliden K, Wahren B. All cases of intrauterine fetal death should be evaluated for parvovirus B19 viral deoxyribonucleic acid. Am J Obstet Gynecol 1999;180(6 Pt 1):1595-6.
  12. Aberham C, Pendl C, Gross P, Zerlauth G, Gessner M. A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA. J Virol Methods 2001;92(2):183-91.
  13. Saito S. Cytokine cross-talk between mother and the embryo/placenta. J Reprod Immunol 2001;52(1-2):15-33.
  14. Norbeck O, Papadogiannakis N, Petersson K, Hirbod T, Broliden K, Tolfvenstam T. Revised clinical presentation of parvovirus B19-associated intrauterine fetal death. Clin Infect Dis 2002 ;35(9):1032-8.
  15. Landolsi H, Yacoubi MT, Bouslama L, Lahmar A, Trabelsi A, Hmissa S, et al.. Detection of the human parvovirus B19 in nonimmune hydrops fetalis using immunohistochemistry and nested-PCR in formalin-fixed and paraffin-embedded placenta and fetal tissues. Pathol Biol (Paris) 2009;57(3):e1-e7.
  16. Quemelo PR, Lima DM, da Fonseca BA, Peres LC. Detection of parvovirus B19 infection in formalin-fixed and paraffin-embedded placenta and fetal tissues. Rev Inst Med Trop Sao Paulo 2007;49(2):103-7.
  17. Syridou G, Spanakis N, Konstantinidou A, Piperaki ET, Kafetzis D, Patsouris E, et al. Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: association with pathological findings. J Med Virol 2008;80(10):1776-82.
  18. Harger JH, Adler SP, Koch WC, Harger GF. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 1998;91(3):413-20.
  19. Jensen IP, Thorsen P, Jeune B, Moller BR, Vestergaard BF. An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors. BJOG 2000;107(5):637-43.
  20. Levy R, Weissman A, Blomberg G, Hagay ZJ. Infection by parvovirus B 19 during pregnancy: a review. Obstet Gynecol Surv 1997;52(4):254-9.
  21. Al-Buhtori M, Moore L, Benbow EW, Cooper RJ. Viral detection in hydrops fetalis, spontaneous abortion, and unexplained fetal death in utero. J Med Virol 2011;83(4):679-84.
  22. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998;105(2):174-8.